Read the latest news articles on transplantation medicine, new treatments for organ transplant recipients and ImmunoFree.
In yet another sign of xenotransplantation creeping toward reality, a medical team at NYU Langone Health announced Tuesday that, for the third time, a kidney from a genetically modified pig had been transplanted into a living patient.
A new lawsuit filed Aug. 20 in federal court in Portland sheds light on the enormous financial and human costs of the complex clinical trials that underlie modern pharmaceutical breakthroughs.
Surgeons at NYU Langone Health performed the first combined mechanical heart pump and gene-edited pig kidney transplant surgery.
In the fall of 2021, Gabriel Arias felt like his body was “rotting from the inside.” He was diagnosed with acute myeloid leukemia, a form of blood cancer so aggressive that doctors had him hospitalized the day of his biopsy.
The National Kidney Foundation (NKF) announced today its latest strategic investment through its NKF Innovation Fund. The fund will support ImmunoFree, a pioneering biomedical company dedicated to reshaping the landscape of organ transplantation by eliminating the need for immunosuppressive medications.
A transfusion of mesenchymal stem cells stabilized and, in some cases, improved transplanted lung function in patients with chronic organ rejection.
Two lingering organ transplantation problems remain – supply and immunosuppressive medication.
Using a method they developed for stem cell transplants, a Stanford team has enabled children with immune disorders to receive a new immune system and a matching kidney from a parent.